In This Section

AACR Project GENIE: Participation

To learn about the individual contributors from each institution, visit our Participating Individuals page.


  • Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, England
  • Children’s Hospital of Los Angeles, California
  • Children’s Hospital of Philadelphia Cancer Center, Philadelphia, Pennsylvania
  • Dana-Farber Cancer Institute, Boston, Massachusetts*
  • Duke University (Duke Cancer Institute), Durham, North Carolina
  • Gustave Roussy Cancer Campus, Paris-Villejuif, France*
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York
  • Korea University Anam Hospital
  • Louisiana State University Health Sciences Center New Orleans
  • The Netherlands Cancer Institute, Amsterdam, on behalf of the Center for Personalized Cancer Treatment, Utrecht, The Netherlands*
  • Memorial Sloan Kettering Cancer Center, New York*
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada*
  • Providence Cancer Institute, Portland, Oregon
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland*
  • Swedish Cancer Institute, Seattle, Washington
  • University of California-San Francisco (UCSF Helen Diller Family Comprehensive Cancer Center), San Francisco, California
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
  • University of Miami Sylvester Comprehensive Cancer Center
  • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee*
  • Vall d’ Hebron Institute of Oncology, Barcelona, Spain
  • Wake Forest University Health Sciences (Wake Forest Baptist Medical Center), Winston-Salem, North Carolina
  • Yale University (Yale Cancer Center), New Haven, Connecticut

*founding members

Participating Institutions Requirements

  • Provide 500 genomic records to start; 500 each subsequent year of participation: Data must be CLIA- or ISO-certified
  • Limited Data sets as defined by 45 C.F.R. § 164.514(e) will be provided
  • If de-identified datasets are provided, the process must adhere to the project’s established protocol
  • Maintain IRB approval
  • Meet data standards and deadlines
  • Participate in meetings
  • Participate in committees and subcommittees
  • Execute the Master Participation Agreement and agree to all exhibits, including the Data User Agreement
  • Past GENIE new participant applicants were judged based on these criteria: AACR Project GENIE Participation Evaluation Criteria

Informatics Partners

  • Sage Bionetworks, Seattle, Washington
  • cBioPortal, New York, New York

Criteria for Informatics Strategic Partners

  • Significant prior experience in similar projects
  • Secure, HIPAA-compliant infrastructure
  • Established and accepted platforms
  • Significant bioinformatics expertise

New Participating Institutions

  • The open call for new participating institutions will begin on May 1st, 2022. Find more information about the 2022 GENIE New Participant Open call here.